Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Acceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017.

Nguyen TTM, Lafond KE, Nguyen TX, Tran PD, Nguyen HM, Ha VTC, Do TT, Ha NT, Seward JF, McFarland JW.

Vaccine. 2020 Feb 18;38(8):2045-2050. doi: 10.1016/j.vaccine.2019.12.047. Epub 2020 Jan 27.

2.

Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.

Ba-Nguz A, Shah A, Bresee JS, Lafond KE, Cavallaro K, Shefer A, Donadel M, Seward JF.

Vaccine. 2019 Jun 19;37(28):3646-3653. doi: 10.1016/j.vaccine.2019.05.046. Epub 2019 May 23.

PMID:
31130258
3.

Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Conteh MA, Goldstein ST, Wurie HR, Gidudu J, Lisk DR, Carter RJ, Seward JF, Hampton LM, Wang D, Andersen LE, Arvay M, Schrag SJ, Dawson P, Fombah AE, Petrie CR, Feikin DR, Russell JBW, Lindblad R, Kargbo SAS, Samai M, Mahon BE.

J Infect Dis. 2018 May 18;217(suppl_1):S33-S39. doi: 10.1093/infdis/jiy061.

4.

Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Jarrett OD, Seward JF, Fombah AE, Lindblad R, Jalloh MI, El-Khorazaty J, Dawson P, Burton D, Zucker J, Carr W, Bah MM, Deen GF, George PM, James F, Lisk DR, Pratt D, Russell JBW, Sandy JD, Turay P, Hamel MJ, Schrag SJ, Walker RE, Samai M, Goldstein ST.

J Infect Dis. 2018 May 18;217(suppl_1):S24-S32. doi: 10.1093/infdis/jiy042.

5.

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Samai M, Seward JF, Goldstein ST, Mahon BE, Lisk DR, Widdowson MA, Jalloh MI, Schrag SJ, Idriss A, Carter RJ, Dawson P, Kargbo SAS, Leigh B, Bawoh M, Legardy-Williams J, Deen G, Carr W, Callis A, Lindblad R, Russell JBW, Petrie CR, Fombah AE, Kargbo B, McDonald W, Jarrett OD, Walker RE, Gargiullo P, Bash-Taqi D, Gibson L, Fofanah AB, Schuchat A; STRIVE Study Team.

J Infect Dis. 2018 May 18;217(suppl_1):S6-S15. doi: 10.1093/infdis/jiy020. Erratum in: J Infect Dis. 2018 Jul 2;218(3):508-507.

6.

Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Schuchat A, Seward JF, Goldstein ST, Mahon BE.

J Infect Dis. 2018 May 18;217(suppl_1):S1-S5. doi: 10.1093/infdis/jix665. No abstract available.

7.

Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Carter RJ, Idriss A, Widdowson MA, Samai M, Schrag SJ, Legardy-Williams JK, Estivariz CF, Callis A, Carr W, Webber W, Fischer ME, Hadler S, Sahr F, Thompson M, Greby SM, Edem-Hotah J, Momoh RM, McDonald W, Gee JM, Kallon AF, Spencer-Walters D, Bresee JS, Cohn A, Hersey S, Gibson L, Schuchat A, Seward JF.

J Infect Dis. 2018 May 18;217(suppl_1):S16-S23. doi: 10.1093/infdis/jix657.

8.

Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Fombah AE, Goldstein ST, Jarrett OD, Jalloh MI, El-Khorazaty J, Lisk DR, Legardy-Williams J, Pratt DA, George PM, Russell JBW, Schrag SJ, Dawson P, Deen GF, Carr W, Lindblad R, James F, Bah MM, Yillia JF, Sandy JD, Turay PE, Conteh MA, Slutsker L, Mahon BE, Samai M, Seward JF.

J Infect Dis. 2018 May 18;217(suppl_1):S75-S80. doi: 10.1093/infdis/jix603.

9.

Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.

Jusu MO, Glauser G, Seward JF, Bawoh M, Tempel J, Friend M, Littlefield D, Lahai M, Jalloh HM, Sesay AB, Caulker AF, Samai M, Thomas V, Farrell N, Widdowson MA.

J Infect Dis. 2018 May 18;217(suppl_1):S48-S55. doi: 10.1093/infdis/jix336.

10.

Implementing an Ebola Vaccine Study - Sierra Leone.

Widdowson MA, Schrag SJ, Carter RJ, Carr W, Legardy-Williams J, Gibson L, Lisk DR, Jalloh MI, Bash-Taqi DA, Kargbo SA, Idriss A, Deen GF, Russell JB, McDonald W, Albert AP, Basket M, Callis A, Carter VM, Ogunsanya KR, Gee J, Pinner R, Mahon BE, Goldstein ST, Seward JF, Samai M, Schuchat A.

MMWR Suppl. 2016 Jul 8;65(3):98-106. doi: 10.15585/mmwr.su6503a14.

PMID:
27387395
11.

Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance.

Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller L, Glaser C, Kambhampati A, Shioda K, Aliabadi N, Fischer M, Gregoricus N, Lanciotti R, Nix WA, Sakthivel SK, Schmid DS, Seward JF, Tong S, Oberste MS, Pallansch M, Feikin D.

Clin Infect Dis. 2016 Sep 15;63(6):737-745. doi: 10.1093/cid/ciw372. Epub 2016 Jun 17.

12.

Recommended Childhood and Adolescent Immunization Schedule--United States, 2016.

COMMITTEE ON INFECTIOUS DISEASES; American Academy of Pediatrics.

Pediatrics. 2016 Mar;137(3):e20154531. doi: 10.1542/peds.2015-4531. Epub 2016 Feb 1. No abstract available.

13.

Global Varicella Vaccine Effectiveness: A Meta-analysis.

Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF.

Pediatrics. 2016 Mar;137(3):e20153741. doi: 10.1542/peds.2015-3741. Epub 2016 Feb 16. Review.

14.

Measles 50 Years After Use of Measles Vaccine.

Goodson JL, Seward JF.

Infect Dis Clin North Am. 2015 Dec;29(4):725-43. doi: 10.1016/j.idc.2015.08.001. Review.

PMID:
26610423
15.

Nontherapeutic Use of Antimicrobial Agents in Animal Agriculture: Implications for Pediatrics.

Paulson JA, Zaoutis TE; Council on Environmental Health; Committee on Infectious Diseases.

Pediatrics. 2015 Dec;136(6):e1670-7. doi: 10.1542/peds.2015-3630. Epub 2015 Nov 16. Review.

16.

Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation.

Midgley CM, Watson JT, Nix WA, Curns AT, Rogers SL, Brown BA, Conover C, Dominguez SR, Feikin DR, Gray S, Hassan F, Hoferka S, Jackson MA, Johnson D, Leshem E, Miller L, Nichols JB, Nyquist AC, Obringer E, Patel A, Patel M, Rha B, Schneider E, Schuster JE, Selvarangan R, Seward JF, Turabelidze G, Oberste MS, Pallansch MA, Gerber SI; EV-D68 Working Group.

Lancet Respir Med. 2015 Nov;3(11):879-87. doi: 10.1016/S2213-2600(15)00335-5. Epub 2015 Oct 5.

17.

Recommendations for Prevention and Control of Influenza in Children, 2015-2016.

Committee on Infectious Diseases, American Academy of Pediatrics.

Pediatrics. 2015 Oct;136(4):792-808. doi: 10.1542/peds.2015-2920. Epub 2015 Sep 7.

18.

Children and Adolescents Unvaccinated Against Measles: Geographic Clustering, Parents' Beliefs, and Missed Opportunities.

Smith PJ, Marcuse EK, Seward JF, Zhao Z, Orenstein WA.

Public Health Rep. 2015 Sep-Oct;130(5):485-504.

19.

Varicella zoster virus infection.

Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K.

Nat Rev Dis Primers. 2015 Jul 2;1:15016. doi: 10.1038/nrdp.2015.16. Review.

20.

Interim CDC guidance for polio vaccination for travel to and from countries affected by wild poliovirus.

Wallace GS, Seward JF, Pallansch MA; Centers for Disease Control and Prevention.

MMWR Morb Mortal Wkly Rep. 2014 Jul 11;63(27):591-4.

21.

Measles - United States, January 1-May 23, 2014.

Gastañaduy PA, Redd SB, Fiebelkorn AP, Rota JS, Rota PA, Bellini WJ, Seward JF, Wallace GS; Division of Viral Disease, National Center for Immunization and Respiratory Diseases, CDC.

MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):496-9.

22.

Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience.

Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean HQ, Rota JS, Bellini WJ, Seward JF.

JAMA Pediatr. 2014 Feb;168(2):148-55. doi: 10.1001/jamapediatrics.2013.4342.

PMID:
24311021
23.

A global perspective of vaccination of healthcare personnel against measles: systematic review.

Fiebelkorn AP, Seward JF, Orenstein WA.

Vaccine. 2014 Aug 27;32(38):4823-39. doi: 10.1016/j.vaccine.2013.11.005. Epub 2013 Nov 24. Review.

24.

Impact of varicella vaccination on varicella-related hospitalizations among American Indian/Alaska Native people.

Singleton RJ, Holman RC, Person MK, Steiner CA, Redd JT, Hennessy TW, Groom A, Holve S, Seward JF.

Pediatr Infect Dis J. 2014 Mar;33(3):276-9. doi: 10.1097/INF.0000000000000100.

PMID:
24136373
25.

Single-dose varicella vaccine effectiveness in school settings in China.

Wang Z, Yang H, Li K, Zhang A, Feng Z, Seward JF, Bialek SR, Wang C.

Vaccine. 2013 Aug 20;31(37):3834-8. doi: 10.1016/j.vaccine.2013.06.075. Epub 2013 Jul 8.

26.

Varicella disease in Beijing in the era of voluntary vaccination, 2007 to 2010.

Lu L, Wang C, Suo L, Li J, Liu W, Pang X, Seward JF.

Pediatr Infect Dis J. 2013 Aug;32(8):e314-8. doi: 10.1097/INF.0b013e31828d948b.

27.

Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.

Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, Lizama A, Diras D, Mathew A, Camacho EJ, Monforte MN, Chen TH, Mahamud A, Kutty PK, Hickman C, Bellini WJ, Seward JF, Gallagher K, Fiebelkorn AP.

Pediatr Infect Dis J. 2013 Apr;32(4):374-80. doi: 10.1097/INF.0b013e318279f593.

28.

Editorial commentary: A rare event: a measles outbreak in a population with high 2-dose measles vaccine coverage.

Seward JF, Orenstein WA.

Clin Infect Dis. 2012 Aug;55(3):403-5. doi: 10.1093/cid/cis445. Epub 2012 Apr 27. No abstract available.

PMID:
22543021
29.

Varicella in infants after implementation of the US varicella vaccination program.

Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, Seward JF.

Pediatrics. 2011 Dec;128(6):1071-7. doi: 10.1542/peds.2011-0017. Epub 2011 Nov 28.

PMID:
22123875
30.

Near elimination of varicella deaths in the US after implementation of the vaccination program.

Marin M, Zhang JX, Seward JF.

Pediatrics. 2011 Aug;128(2):214-20. doi: 10.1542/peds.2010-3385. Epub 2011 Jul 25.

PMID:
21788222
31.

Health care-associated measles outbreak in the United States after an importation: challenges and economic impact.

Chen SY, Anderson S, Kutty PK, Lugo F, McDonald M, Rota PA, Ortega-Sanchez IR, Komatsu K, Armstrong GL, Sunenshine R, Seward JF.

J Infect Dis. 2011 Jun 1;203(11):1517-25. doi: 10.1093/infdis/jir115. Epub 2011 Apr 28.

PMID:
21531693
32.

Laboratory characteristics of suspected herpes zoster in vaccinated children.

Chun C, Weinmann S, Riedlinger K, Mullooly JP, Houston H, Schmid DS, Seward JF.

Pediatr Infect Dis J. 2011 Aug;30(8):719-21. doi: 10.1097/INF.0b013e3182137e35.

PMID:
21346684
33.

Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids.

Frenck RW Jr, Seward JF.

Arthritis Care Res (Hoboken). 2010 Jul;62(7):903-6. doi: 10.1002/acr.20234. No abstract available.

34.

Guidance for isolation precautions for mumps in the United States: a review of the scientific basis for policy change.

Kutty PK, Kyaw MH, Dayan GH, Brady MT, Bocchini JA, Reef SE, Bellini WJ, Seward JF.

Clin Infect Dis. 2010 Jun 15;50(12):1619-28. doi: 10.1086/652770. Review.

PMID:
20455692
35.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

36.

Measles outbreak associated with an international youth sporting event in the United States, 2007.

Chen TH, Kutty P, Lowe LE, Hunt EA, Blostein J, Espinoza R, Dykewicz CA, Redd S, Rota JS, Rota PA, Lute JR, Lurie P, Nguyen MD, Moll M, Reef SE, Sinclair JR, Bellini WJ, Seward JF, Ostroff SM.

Pediatr Infect Dis J. 2010 Sep;29(9):794-800. doi: 10.1097/INF.0b013e3181dbaacf.

PMID:
20400927
37.

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics.

MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166.

38.

The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.

Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF.

Pediatr Infect Dis J. 2009 Nov;28(11):954-9. doi: 10.1097/INF.0b013e3181a90b16.

PMID:
19536039
39.

Death and serious illness following influenza vaccination: a multidisciplinary investigation.

Rue-Cover A, Iskander J, Lyn S, Burwen DR, Gargiullo P, Shadomy S, Blostein J, Bridges CB, Haber P, Satzger RD, Ball R, Seward JF.

Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):504-11. doi: 10.1002/pds.1743.

PMID:
19373848
40.

Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003.

Hyde TB, Nandy R, Hickman CJ, Langidrik JR, Strebel PM, Papania MJ, Seward JF, Bellini WJ.

Bull World Health Organ. 2009 Feb;87(2):93-8.

41.

Mumps epidemiology and immunity: the anatomy of a modern epidemic.

Anderson LJ, Seward JF.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S75-9. doi: 10.1097/INF.0b013e3181684d8d.

PMID:
18820583
42.

Varicella prevention in the United States: a review of successes and challenges.

Marin M, Meissner HC, Seward JF.

Pediatrics. 2008 Sep;122(3):e744-51. doi: 10.1542/peds.2008-0567. Review.

PMID:
18762511
43.

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.

44.

Varicella among adults: data from an active surveillance project, 1995-2005.

Marin M, Watson TL, Chaves SS, Civen R, Watson BM, Zhang JX, Perella D, Mascola L, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S94-S100. doi: 10.1086/522155.

PMID:
18419417
45.

Varicella vaccine effectiveness in the US vaccination program: a review.

Seward JF, Marin M, Vázquez M.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S82-9. doi: 10.1086/522145. Review.

PMID:
18419415
46.
47.

Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.

Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S71-5. doi: 10.1086/522156.

PMID:
18419413
48.

Varicella vaccine in the United States: a decade of prevention and the way forward.

Gershon AA, Arvin AM, Levin MJ, Seward JF, Schmid DS.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S39-40. doi: 10.1086/522165. No abstract available. Erratum in: J Infect Dis. 2008 Jun 15;197(12):1783.

PMID:
18419405
49.

The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.

Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. Review.

PMID:
18419401
50.

Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry.

Wilson E, Goss MA, Marin M, Shields KE, Seward JF, Rasmussen SA, Sharrar RG.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S178-84. doi: 10.1086/522136.

PMID:
18419394

Supplemental Content

Loading ...
Support Center